| Date Filed | Type | Description |
| 06/02/2023 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 05/19/2023 |
4
| Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,454 options to buy
@ $189.87, valued at
$655.8k
|
|
| 02/27/2023 |
4
| Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Exercised 136 restricted stock units
@ $0 |
|
| 10/14/2022 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 52,532 shares
@ $0
Unknown transaction of 7,250 shares
@ $0
Disposed/sold 14,026 options to buy
@ $5.05, valued at
$70.8k
Disposed/sold 28,053 options to buy
@ $5.43, valued at
$152.3k
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 09/19/2022 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 06/16/2022 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.53, valued at
$10.6k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
| 06/28/2021 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.97, valued at
$39.7k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $6.3, valued at
$110.3k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.17, valued at
$160.5k
|
|
| 11/22/2019 |
4
| Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 75,000 shares
@ $100, valued at
$7.5M
Exercised 30,000 options to buy
@ $9.14, valued at
$274.2k
Exercised 15,000 options to buy
@ $11.33, valued at
$170k
Exercised 15,000 options to buy
@ $9.3, valued at
$139.5k
Exercised 15,000 options to buy
@ $30.09, valued at
$451.4k
|
|
| 07/02/2019 |
4
| Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
| 06/12/2019 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.6, valued at
$61.6k
|
|
| 06/04/2019 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.95, valued at
$139.5k
|
|
| 04/03/2019 |
4/A
| Fanucci Marsha (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 13,671 shares
@ $0
Granted 3,279 shares
@ $0 |
|
| 04/03/2019 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 13,671 shares
@ $0
Granted 3,279 shares
@ $0 |
|
| 04/03/2019 |
4
| Fanucci Marsha (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Disposed/sold 4,056 shares
@ $0 |
|
| 03/15/2019 |
3
| Fanucci Marsha (Director) has filed a Form 3 on Cyclerion Therapeutics, Inc. |
| 03/14/2019 |
3
| Fanucci Marsha (Director) has filed a Form 3 on IRONWOOD PHARMACEUTICALS INC |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| Fanucci Marsha (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
| 06/04/2018 |
4
| Fanucci Marsha (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 16,223 shares
@ $0 |
|
| 09/22/2017 |
4/A
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $0 |
|
| 06/12/2017 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $14.26, valued at
$156.9k
|
|
|